-
- Aranami Toshimasa
- Department of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry
-
- Yamamura Takashi
- Department of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry
この論文をさがす
抄録
Multiple sclerosis (MS) is a CD4+ T cell-mediated autoimmune disease affecting the central nervous system. It was largely accepted that Th1 cells driven by IL-12 were pathogenic T cells in human MS and experimental autoimmune encephalomyelitis, an animal model of MS. Recent data have established that IL-17-producing CD4+ T cells, driven by IL-23 and referred to as Th17 cells, play a pivotal role in the pathogenesis of EAE. A combination of TGF-β and IL-6 induce Th17 cell lineage commitment via expression of transcription factor RORγt. Th17 cells and induced Foxp3+ T regulatory cells are in reciprocal position in the T cell lineage commitment governed by TGF-β and IL-6. The vitamin A metabolite retinoic acid is involved in this process via TGF-β dependent induction of Foxp3. We have demonstrated that human Th17 cells could be identified as CCR2+ CCR5- memory CD4+ T cells. It is becoming clear that IL-23/Th17 axis also plays an important role in the pathogenesis of various human autoimmune diseases including MS. Additionally, accumulating evidences raise a possibility that CCR2 on Th17 cells may be a therapeutic target in MS.<br>
収録刊行物
-
- Allergology International
-
Allergology International 57 (2), 115-120, 2008
一般社団法人日本アレルギー学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390001204632090496
-
- NII論文ID
- 10021246298
- 130004476964
-
- NII書誌ID
- AA11091750
-
- COI
- 1:CAS:528:DC%2BD1cXotFGhsrk%3D
-
- ISSN
- 14401592
- 13238930
-
- PubMed
- 18427164
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可